Embracing complexity: a fly approach to developing new cancer therapeutics

29 Jul

Ross Cagan, Icahn School of Medicine at Mount Sinai, New York, USA Current efforts at ‘personalised medicine’ primarily focus on using genomic analysis to identify the best therapeutic target. This has shown some success but, overall, precision therapies have struggled to stably reverse tumour progression. In recent years, my laboratory has used Drosophila to explore […]

Plenary talk: Dr Luis Parada

25 Apr

Luis F. Parada grew up in Bogota, Colombia.  He obtained a BS from the University of Wisconsin and a Ph.D. in Biology from MIT in 1985 identifying oncogenes in human cancer.  He was a Damon Runyon and later Helen Hay Whitney Postdoctoral Fellow at the Pasteur Institute.   From 1988 to 1994, he headed the Molecular […]

Plenary talk: Dr Peter Kuhn

25 Apr

Dr. Kuhn is a scientist and entrepreneur with a career long commitment in personalized medicine and individualized cancer patient care. He is focused on the redesign of cancer care. Dr. Kuhn is leading the Scripps Physics Oncology Centre and is a Founder of Epic Sciences. The Scripps Physics Oncology Centre is shedding new light at how […]

Plenary talk: Professor David Spiegelhalter

25 Apr

David Spiegelhalter is Winton Professor for the Public Understanding of Risk, and Professor of Biostatistics, at the University of Cambridge. His background is in medical statistics, particularly the use of Bayesian methods in clinical trials, health technology assessment and drug safety. In his post he leads a small team (UnderstandingUncertainty.org) that attempts to improve the […]

View All

Features

exhibition_300x200

Sponsor and exhibit

Support the 10th NCRI Cancer Conference and showcase your products and services.
registration_300x200

Register

Benefit from the earlybird rate and gain 24 CPD points.
Focusonpeople_300x200

Focus on…People

See the experts you will meet in 2014.
View All

Praise from the 2013 NCRI Conference

Inspiring to hear about the work going on and to network with colleagues from across the country

Collaboration forum between clinicians and researchers highlights UK achievements.

The themed parallel sessions made it easier to decide which sessions would be most appropriate. The diverse range of topics covered – it is interesting to see cancer research from the point of view of e.g. clinicians when I work in a medicinal chemistry lab

This site is protected by Comment SPAM Wiper.